Welcome to our dedicated page for BlackRock Science and Technology Trust SEC filings (Ticker: BST), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock Science and Technology Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock Science and Technology Trust's regulatory disclosures and financial reporting.
BST filed an N-CEN annual report providing operational disclosures for its registered investment company, including securities lending, brokerage commissions and principal transaction totals.
The filing reports a monthly average value of portfolio securities on loan of 1,796,048.39 and securities lending net income of 40,547. It lists aggregate brokerage commissions of 462,928.40 and principal transaction values of 4,315,869, 336,221.15, and 637,992,755000.
BlackRock Science and Technology Trust filed a Form N-CSR certifying shareholder reports for the fiscal period ended 12/31/2025, including supplemental information on distributions and portfolio summaries for BST and affiliated BlackRock closed‑end funds. The filing presents each Trust’s managed distribution plan and monthly fixed distribution amounts (for BST: $0.250000 per share; annualized $3.000000), and shows distribution composition tables by source for multiple Trusts as of 12/31/2025.
The filing also discloses that, effective 11/10/2025, several Trusts (including BST and related term trusts) removed an options writing strategy as a principal investment strategy and changed benchmarks where noted. Performance, portfolio positioning, top holdings, sector allocations, and risk disclosures are provided for each Trust in the report.
BlackRock Science & Technology Trust (BST) reported an insider share purchase by portfolio manager Tony Kim. On February 5, 2026, he bought 1,200 common shares at $38.87 each and another 22,445 common shares at $38.90 each in open-market transactions, all held directly.
BlackRock Science & Technology Trust portfolio manager Steven Reid Menge reported compensation-related share activity. On January 30, 2026, he received 793.234 phantom shares, which are cash-settled units economically equivalent to common stock and subject to vesting over three years.
On the same day, previously granted phantom shares were partially converted into 563.9956 common shares, which were then sold at $40.94 per share, leaving no directly held common stock. Additional phantom-share tranches from 2023–2025 grants continue to vest in equal annual installments.
BlackRock Science & Technology Trust portfolio manager Tony Kim reported multiple compensation-related transactions dated January 30, 2026. He was granted 5,612.5061 phantom shares, each economically equivalent to one common share and payable in cash upon vesting in three annual installments. On the same date, previously granted phantom shares from 2023–2025 awards were partially converted into common stock through several “M” (exercise) transactions. Kim then disposed of 8,314.3546 common shares at $40.94 per share, leaving him with 57,514 common shares held directly after the reported sale.
BlackRock Science & Technology Trust portfolio manager Tony Kim reported a purchase of common shares. On January 23, 2026, he bought 16,000 shares of the trust’s common stock in an open market transaction coded “P” at a price of $40.70 per share. Following this transaction, Kim directly owned 57,514 common shares of BlackRock Science & Technology Trust.